All Access Articles |
- FDA Approves Imcivree for Acquired Hypothalamic Obesity | 2026-03-20 | UNITED STATES
- Rhythm Pharmaceuticals Reports Positive Data on Setmelanotide | 2026-03-02 | UNITED STATES
- Rhythm Pharmaceuticals Reports $57.3M in Q4 Revenue | 2026-02-26 | UNITED STATES
- What Our Analysts Know About Rhythm Pharmaceuticals | 2025-12-11 | UNITED STATES